Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

*Product:*	Dapagliflozin Sandoz
Active Ingredient:	Dapagliflozin 10mg
Dosage Form:	Film coated tablet
New Zealand Sponsor:	Sandoz New Zealand Limited
Manufacturer:	Sandoz Private Limited, Navi Mumbai, India

*Product:*	Sea-Legs Double-Strength
Active Ingredient:	Meclozine hydrochloride 25mg
Dosage Form:	Chewable tablet
New Zealand Sponsor:	iNova Pharmaceuticals (New Zealand) Limited
Manufacturer:	Unique Pharmaceuticals Laboratories, a Division of J.B. Chemicals & Pharmaceuticals Limited, Panoli, India

Dated this 14th day of April 2026.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule